Submission Details
| 510(k) Number | K014193 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 2001 |
| Decision Date | May 23, 2002 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K014193 is an FDA 510(k) clearance for the LIFESIGN DOA 4 (THC/OPI/COC/MET), a Enzyme Immunoassay, Cannabinoids (Class II — Special Controls, product code LDJ), submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on May 23, 2002, 153 days after receiving the submission on December 21, 2001. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3870.
| 510(k) Number | K014193 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 2001 |
| Decision Date | May 23, 2002 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | LDJ — Enzyme Immunoassay, Cannabinoids |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3870 |